Numerous hospitals that receive federal funding are reportedly continuing to offer body-mutilating sex change procedures to minors despite President Donald Trump’s recent executive order vowing to slash funding for such facilities.
Altogether, 37 federally-funded hospitals providing surgical procedures or drugs to individuals under 18 who have gender dysphoria confirmed to the Daily Caller that they are still administering so-called interventions such as puberty blockers, cross-sex hormones, and, in some cases, surgery. The list of hospitals was compiled by the Trans Health Project.
A staff member at Boston Medical Center told the Daily Caller that, based on their understanding, the executive order has not altered the services offered by their providers.
Get Our Latest News for FREE
Subscribe to get daily/weekly email with the top stories (plus special offers!) from The Christian Post. Be the first to know.
Similarly, a front desk employee at Bay State Medical Center in Massachusetts indicated no changes had been communicated regarding the provision of so-called “gender-affirming care” for minors. The employee also noted there had been a recent surge in new patient inquiries.
Trump issued an executive order on Jan. 28 targeting federal funding for medical institutions involved in what the order described as the “chemical and surgical mutilation of children.” The directive instructed agency heads overseeing research or educational grants to ensure compliance with the funding restriction in coordination with the Office of Management and Budget.
“It is the policy of the United States that it will not fund, sponsor, promote, assist, or support the so-called ‘transition’ of a child from one sex to another, and it will rigorously enforce all laws that prohibit these destructive and life-altering procedures,” the order said.
Some hospitals the Daily Caller contacted affirmed they are providing not only puberty blockers and hormone therapy but also surgical interventions or referrals for minors. A staff member at the University of Minnesota Health noted that her employer is seeing patients as young as 14 for “top surgery” — a euphemism for mastectomies of young girls.
Mount Sinai’s Center for Transgender Medicine and Surgery in New York City confirmed to the Daily Caller that they offer surgical options for minors seeking to transition, with decisions made individually by physicians without a fixed age limit.
Children’s Hospital Colorado pointed to ongoing lawsuits against Trump’s order as justification for resuming gender transition treatments, including puberty blockers and hormone therapy, as stated in a voicemail from their True Center for Gender Diversity.
The University of Michigan’s medical center told the Caller it provides hormone therapy to patients under 18. Michigan Medicine reported receiving $482.8 million from NIH in fiscal year 2023, ranking it 11th among federally funded research institutions.
Legal challenges from states like Washington, Oregon, Minnesota and Colorado resulted in a preliminary injunction granted by a Biden-appointed judge in Seattle on Feb. 28. A separate ruling from a Baltimore federal judge, also appointed by Biden, mandated continued funding for hospitals offering these services during an American Civil Liberties Union lawsuit.
Some hospitals have scaled back transgender services for minors following Trump’s order.
The University of Virginia stopped accepting new patients for youth gender treatments, with a representative confirming no medications are offered to those under 19.
Children’s National Hospital also paused new hormone therapies and refills, citing the order, though they continue to provide behavioral health support.
“I think, as a whole, hospitals are afraid of providers losing their license if they continue to do it under the executive order, so … it’s the best guidance for the time being,” a representative told the conservative outlet.
The “Cass Review,” a comprehensive four-year study commissioned by the National Health Service in England, questioned the efficacy of puberty blockers for children with gender dysphoria, citing limited evidence of mental health benefits and concerns over long-term effects. The NHS consequently restricted such treatments to clinical research settings.
Jon Brown is a reporter for The Christian Post. Send news tips to jon.brown@christianpost.com
Be the first to comment